Dietary phytoestrogens: potential selective estrogen enzyme modulators?
Between one-third to one-half of all breast cancers are steroid sensitive. Steroid-pathway enzymes (sulfatase, 17beta-hydroxysteroid dehydrogenases, aromatase and sulfotransferases) are thus prime candidates for therapeutic approaches based on the control of intacrine activity. Some phytoestrogens, ubiquitous in our diet, are inhibitors of these enzymes. Such a therapeutic potential has stimulated research and progress has been achieved during the last years. Complementary to previous reviews on phytoestrogens, this contribution covers the estrogen pathway inhibition effects of these compounds and special attention will be given to isoflavonoids, flavonoids and lignans. Furthermore, the research on structurally-related compounds as therapeutic agents will be discussed briefly.
Basly
Jean-Philippe
JP
Faculté de Pharmacie, Université de Limoges, Limoges, France. basly@pharma.unilim.fr
Lavier
Marie-Chantal Canivenc
MC
D001943:Breast Neoplasms / Q000201:enzymology / Q000517:prevention & control*; D019587:Dietary Supplements; D005260:Female; D006801:Humans; D048789:Phytoestrogens / Q000008:administration & dosage*; D008517:Phytotherapy; D020845:Selective Estrogen Receptor Modulators / Q000008:administration & dosage*
D048789:Phytoestrogens; D020845:Selective Estrogen Receptor Modulators